Browse by author
Lookup NU author(s): Jonathan Hollick, Dr Laurent Rigoreau, Dr Celine CanoORCiD, Professor Nicola CurtinORCiD, Emeritus Professor Bernard Golding, Sophie Guiard, Dr Ian HardcastleORCiD, Professor Herbie Newell, Professor Roger Griffin
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Structure-activity relationships have been investigated for inhibition of DNA-dependent protein kinase (DNA-PK) and ATM kinase by a series of pyran-2-ones, pyran-4-ones, thiopyran-4-ones, and pyridin-4-ones. A wide range of IC50 values were observed for pyranones and thiopyranones substituted at the 6-position, with the 3- and 5-positions proving intolerant to substitution. Related pyran-2-ones, pyran-4-ones, and thiopyran-4-ones showed similar IC50 values against DNA-PK, whereas the pyridin-4-one system proved, in general, ineffective at inhibiting DNA-PK. Extended libraries exploring the 6-position of 2-morpholinopyran-4-ones and 2-morpholino- thiopyrano-4-ones identified the first highly potent and selective ATM inhibitor 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (151C; ATM; IC50 = 13 nM) and revealed constrained SARs for ATM inhibition compared with DNA-PK. One of the most potent DNA-PK inhibitors identified, 2-(4-methoxyphenyl)-6- (morpholin-4-yl)pyran-4-one (16; DNA-PK; IC50 = 220 nM) effectively sensitized HeLa cells to the topoisomerase II inhibitor etoposide in vitro. © 2007 American Chemical Society.
Author(s): Hollick J, Rigoreau L, Cano-Soumillac C, Cockcroft X, Curtin NJ, Frigerio M, Golding BT, Guiard S, Hardcastle IR, Hickson I, Hummersone M, Menear K, Martin N, Matthews I, Newell DR, Ord R, Richardson C, Smith G, Griffin RJ
Publication type: Article
Publication status: Published
Journal: Journal of Medicinal Chemistry
Year: 2007
Volume: 50
Issue: 8
Pages: 1958-1972
Print publication date: 19/04/2007
Date deposited: 29/04/2010
ISSN (print): 0022-2623
ISSN (electronic): 1520-4804
URL: http://dx.doi.org/10.1021/jm061121y
DOI: 10.1021/jm061121y
PubMed id: 17371003
Altmetrics provided by Altmetric